<DOC>
	<DOCNO>NCT00006117</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness gemcitabine oxaliplatin treat patient locally advance metastatic pancreatic cancer .</brief_summary>
	<brief_title>Gemcitabine Oxaliplatin Treating Patients With Locally Advanced Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine objective tumor response rate patient locally advance metastatic pancreatic carcinoma treat gemcitabine oxaliplatin . II . Determine tolerablility clinical benefit regimen patient . III . Evaluate progression free survival overall survival patient treat regimen . OUTLINE : This multicenter study . Patients receive gemcitabine IV day 1 1.5 hour oxaliplatin IV 2 hour day 2 . Treatment continue every 2 week absence disease progression unacceptable toxicity . Patients locally advanced disease receive 6-8 course may undergo surgery , radiotherapy , and/or additional chemotherapy . PROJECTED ACCRUAL : A total 66 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm metastatic locally advanced unresectable adenocarcinoma pancreas Measurable disease At least 2 cm diameter No known brain metastasis PATIENT CHARACTERISTICS : Age : 18 75 Performance status : ECOG 02 OR Karnofsky 60100 % Life expectancy : Greater 12 week Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) Alkaline phosphatase great 5 time ULN Renal : Creatinine great 1.5 time ULN Cardiovascular : Adequate cardiac function Pulmonary : Adequate respiratory function Other : Not pregnant nursing Fertile patient must use effective contraception No sensitive neuropathy No active malignancy No uncontrolled hypercalcemia No significant medical psychiatric condition would preclude study No psychological , familial , sociological , geographical condition would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy Chemotherapy : No prior chemotherapy Endocrine therapy : No concurrent corticosteroid use except antiemetic Radiotherapy : No prior radiotherapy Surgery : Not specify Other : No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
</DOC>